Skip to main content
Premium Trial:

Request an Annual Quote

Amersham, GeneticXchange Soon to Sell Co-Developed Data-Integration Tool

NEW YORK, July 10 - Amersham Biosciences and GeneticXchange have co-developed a platform to help researchers integrate lab-generated data with legacy, public, third party, and clinical data, the firms said today.

The platform brings together Amersham's Scierra Laboratory Workflow System with GeneticXchange's discoveryHub data-integration platform. It will be available during the current quarter, and Amersham will sell it worldwide.

 

Financial terms were not disclosed. 

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.